WuXi PharmaTech Appoints Dr. Chi-Chung Chan as Vice President of Pharmacology
SHANGHAI, July 23 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Dr. Chi-Chung Chan has been appointed...WuXi PharmaTech Files 2008 Annual Report on Form 20-F
SHANGHAI, June 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that it filed its annual report on Form 20-F for the year ended December 31, 2008 with the Securities and Exchange Commission. The annual report can be accessed on WuXi PharmaTech's website at h...WuXi PharmaTech Announces First-Quarter 2009 Results
SHANGHAI, China, May 14 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financi...WuXi PharmaTech Appoints Hao Zhou as Vice President of Finance
SHANGHAI, May 5 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) today announced that it has appointed Hao Zhou as Vice President of Finance. (Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO ) Prior to joining WuXi PharmaTech, Mr. Zhou worked for eleven years at...WuXi PharmaTech Schedules Fourth Quarter 2008 Earnings Release on Thursday, March 26, 2009
SHANGHAI, March 12 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the fourth quar...WuXi PharmaTech Announces CFO Benson Tsang to Leave Company; COO Edward Hu Named Acting CFO
SHANGHAI, Feb. 17 /PRNewswire-Asia/ -- WuXi PharmaTech (NYSE: WX ) announced today that Benson Tsang, Chief Financial Officer, is leaving the company for personal reasons at the end of February. Edward Hu, Chief Operating Officer, will serve as acting Chief Financial Officer until a replace...WuXi PharmaTech Appoints Stewart Hen and Ning Zhao to Its Board of Directors; Tao Lin Leaves Board
SHANGHAI, China, Feb. 5 /PRNewswire-Asia/ - WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced the addition of Stewart Hen and Ning...WuXi PharmaTech to Present at 20th Annual Piper Jaffray Healthcare Conference
SHANGHAI, China, Nov. 27 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced Edward Hu, the Company's Chief Operatin...WuXi PharmaTech Expands Collaboration for Fully Integrated Services
SHANGHAI, China, Oct. 16 /Xinhua-PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced it has reached an agreement with J...Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
...ma, Chronic Myelogenous Leukemia, and Non-Small Cell Lung Cancer (NSCLC). pharmatech will manage the trials using its innovative JIT approach. This streamlined ...ion of approximately 165 Pharmatech Research Network sites. Matthew Wiener, pharmatech CEO, states that "The recent activity in new business has been a true testa...Quest PharmaTech's Prostate Cancer Program Update
...ical trial for the same indications. In addition, SL017 is currently undergoing a Canadian Phase I clinical trial for Actinic Keratosis. About Quest pharmatech Inc. The Corporation is a publicly traded , Alberta-based drug development company committed to the development and commercialization of new pharmac...WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
SHANGHAI, July 20 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial results for the second quart...WuXi PharmaTech Receives Award from BASF
SHANGHAI, July 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had received an award from BASF for excellent service and outstanding contributions in the area of custom synthesis for new crop-protection active ingredients. (Logo: http://www.ne...WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
SHANGHAI, June 29 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) announced today that it had been selected by China's Ministry of Commerce to the list of Top Ten Leading Outsourcing Enterprises in China. The list was announced at the Second Annual China International Service ...WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
SHANGHAI, June 22 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, today announced that Felix Hsu has been appointed Senior ...WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
SHANGHAI, June 16 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ) today announced that Edward Hu, the Company's Chief Operating Officer and acting Chief Financial Officer, will present at the Third Annual Jefferies Healthcare Conference in New York on Wednesday, June 17, 2009,...WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
Earnings Conference Call to be Held on May 15, 2009 at 8:00 am (Eastern) / 5:00 am (Pacific) / 8:00 pm (Beijing/Shanghai/Hong Kong) SHANGHAI, May 1 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ...WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
SHANGHAI, March 25 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), a leading research and development outsourcing company serving the pharmaceutical, biotechnology, and medical device industries, with operations in China and the United States, today announced its financial re...The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
AURORA, Colo., March 18 /PRNewswire/ -- Pharmatech Oncology has been selected by the Fitzsimons Redevelopment Authority to be a preferred vendor to the Colorado Science + Technology Park at Fitzsimons. The Technology Park is home to 25 pharmaceutical and biotechnology companies. The majority of ...